Response Biomedical Corp

Response Biomedical is commercializing a new class of diagnostic with the world's only immunoassay platform that provides lab quality information in a matter of minutes, anywhere, every time. RAMP® tests are commercially available for three cardiac markers used in the early detection of heart attack, environmental detection of West Nile virus, and biodefense applications including the detection of anthrax, ricin, smallpox, and botulinum toxin.For clinical applications, RAMP is to be used by healthcare professionals at the point-of-care, including physicians' offices, medical clinics, hospital emergency departments and laboratories worldwide. The Company has received regulatory clearance from Health Canada and the US Food and Drug Administration to market its RAMP Cardiac Marker Tests for detecting myoglobin, troponin I and CK-MB to assist in the rapid diagnosis of heart attack or acute myocardial infarction. Rapid diagnosis of heart attacks is critical to patient outcomes. Cardiac markers are proteins released in the blood following a heart attack. RAMP provides a quantitative result in approximately 15 minutes, compared to several hours turnaround time for traditional laboratory testing. The results from independent multi-center US clinical trials of RAMP tests for troponin I and CK-MB demonstrated improved performance over the current market leading quantitative point-of-care system.
The Company is expanding its international marketing and distribution network, as it pursues further clinical applications in stroke, oncology and infectious disease testing. The Company has achieved CE Mark and its Quality Management System is registered to ISO 9000: 2000 and ISO 13485:1996.

Contact Details: 100-8900 Glenlyon Parkway Burnaby British Columbia V5J 5J8 Canada Tel: Fax: 604.456.6066 Email: info@responsebio.com WWW: www.responsebio.com/

Loading...

Recent Publications by Response Biomedical Corp:
RAMP anthrax test cartridge. A study has been made of the application of radio frequency (RF)...	29th July, 2005	Response Biomedical Corp., 8081 Lougheed Hwy, Burnaby, British Columbia	J AOAC Int. 2005 Jan-Feb;88(1):202-3.

BioNews Results for Response Biomedical Corp:
Response Biomedical Corporation Announces Second Quarter Results	Macro World Investor:  Aug 14 2008 11:12PM Matching: response biomedical corp
Response Biomedical Corporation Announces Second Quarter Results	Clinical Lab Products:  Aug 14 2008 9:57PM Matching: response biomedical corp
Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure	Therapeutics Daily:  Jul 22 2008 1:07PM Matching: response biomedical corp

Response Biomedical Corp Patents:
US Patent No.	Title
7056473	Method and apparatus of quantitative assays
6509196	Compensation for non-specific signals in quantitative immunoassays

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 135 times since April 2007, the link to the organisation's website has been followed 26 times

Search for more companies in Burnaby

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Response Biomedical Corp